The Filing Desk

Sight Sciences vs TELA Bio

Sight Sciences SGHT · TELA Bio TELA · Health Care Equipment

TELA Bio reported revenue of $80 million in fiscal 2025, about the same as Sight Sciences' $77 million in fiscal 2025. Sight Sciences' revenue fell 3.1% in its latest year, and TELA Bio's grew 15.8%. Sight Sciences had an operating margin of -48.0%, against -42.0% at TELA Bio. Free cash flow was −$30 million at Sight Sciences and −$29 million at TELA Bio.

Side by side

Sight SciencesTELA Bio
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$77M$80M
Revenue growth−3.1%15.8%
Revenue growth a year, last 5 years22.9%34.6%
Gross margin86.2%67.7%
Operating margin−48.0%−42.0%
Net margin−49.7%−48.4%
Free cash flow−$30M−$29M
Free cash flow margin−38.7%−35.7%
Return on capital—−190.2%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count4.0%64.6%
Last close$10.62$0.73
P/E at the last close——
Insider trades, last 12 monthsbought $184,799, sold $2.3 millionbought $186,250, sold $0
Piotroski F-score5 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Sight SciencesTELA Bio
Operating margin
Percent of revenue
Sight SciencesTELA Bio
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Sight SciencesTELA Bio

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Sight Sciences and TELA Bio pages.